Company
Operations
Pantherics Incorporated has corporate offices in La Jolla, CA and Madison, WI. Research is conducted at the University of Wisconsin-Milwaukee, Columbia University, Ohio State University, and the Medical College of Wisconsin/Children’s Hospital of Wisconsin.
Research leading to clinical candidate MIDD0301 has been supported by public and private funding, including the following:
Executive Management
Douglas Stafford, PhD, MS
President and Chief Executive Officer
Director of the Milwaukee Institute for Drug Discovery and Executive Director of the Shimadzu Laboratory for Advanced and Applied Analytical Chemistry, Douglas C. Stafford has coauthored numerous scientific publications, is inventor on more than a dozen patents, and has received entrepreneurial achievement awards. Read more ›
Alexander (Leggy) Arnold, PhD
Vice President and Chief Scientific Officer
An Associate Professor at the University of Wisconsin Milwaukee, Arnold is a founding member of the Milwaukee Institute for Drug Discovery. He has published 78 peer-reviewed articles, four book chapter holds two allowed patents. Dr. Arnold is an expert in drug discovery and has been working with the NIH Chemical Genomic Center and their probe discovery program for more than nine years. Read more ›
Loren Peterson, CPA
Vice President and Chief Financial Officer
Loren Peterson is an entrepreneur and business executive with significant experience starting, developing, operating and exiting technology-based companies, mainly in the life sciences industry. Read more ›
John Dobak, MD
Executive Board Chair
John Dobak, MD, has served as Founder and CEO of several venture-backed life science companies in San Diego. Dr. Dobak is the President of the JAKK Group, a life sciences technology accelerator, which has created several companies, including Lithera, INNERCOOL Therapies, and CryoGen/CryoCor. Read more ›
Daniel Piacquadio, MD
Vice President
Active in clinical research and medical product development since 1985, Dr. Piacquadio has also actively participated in the development of a wide variety of biotechnology start-ups and medical product development programs. Read more ›
Bruce Steel, MBA, CFA
Board Member
Bruce is the President, co-founder, and Chief Business Officer of Equillium as well as the founder and Managing Director of BioMed Ventures. Read more ›
Board of Directors
Advisors
Charles Emala, MD, MS
Senior Medical Advisor
Dr. Emala holds the Henrik H Bendixen chair of the Columbia University Department of Anestesiology, where his lab has been funded by the National Institutes of Health for over 20 years. Read more ›